Skinvisible, Inc.
SKVI
$0.23
-$0.07-23.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| SG&A Expenses | 198.70K | 124.00K | 142.90K | 123.50K | 136.80K |
| Depreciation & Amortization | 5.10K | 5.90K | 4.80K | 4.70K | 4.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 203.70K | 130.00K | 147.70K | 128.20K | 141.50K |
| Operating Income | -198.70K | -125.00K | -142.70K | -123.20K | -136.50K |
| Income Before Tax | 314.80K | -286.60K | -303.40K | -290.40K | -303.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 314.80K | -286.60K | -303.40K | -290.40K | -303.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 314.80K | -286.60K | -303.40K | -290.40K | -303.80K |
| EBIT | -198.70K | -125.00K | -142.70K | -123.20K | -136.50K |
| EBITDA | -193.70K | -119.00K | -137.90K | -118.50K | -131.80K |
| EPS Basic | 0.05 | -0.06 | -0.07 | -0.06 | -0.07 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
| EPS Diluted | 0.05 | -0.06 | -0.07 | -0.06 | -0.07 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 6.63M | 4.54M | 4.54M | 4.54M | 4.54M |
| Average Diluted Shares Outstanding | 6.63M | 4.54M | 4.64M | 4.54M | 4.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |